While writing these words, I am thinking that we are halfway through the current year, a time to reflect on the objectives we have set at the beginning of our management. I must say that, with great efforts, we are successfully meeting these objectives.

We have redefined the administrative section of the Argentine Society of Cardiology (Sociedad Argentina de Cardiología, SAC) to achieve a better performance, which will result in important improvements for our Society.

Regarding the projects that involve raising awareness by physicians and the entire community, we are enthusiastic about the bill submitted last May 4 by the Heart and Women Committee to the Argentine National Senate in order to designate a National Day of Women’s Cardiovascular Disease Awareness. In Argentina, 1 out of 3 women die from cardiovascular disease; however, this is a fact that has not yet got the recognition it deserves, and there is an urgent need to achieve this to implement the appropriate prevention measures.

It is also worth mentioning that, in May, the 1st Argentine Symposium on Digital Health organized by the Digital Health Council was held in Rosario. This meeting brought national and international experts together where they discussed different issues related to the application of the information and communication technologies in the cardiology field.

The feedback generated between these disciplines and the cardiology field, on the one hand, helps digital experts to make fewer mistakes when developing their applications, and, on the other hand, helps us, the physicians, to make the most of their services to optimize the development of our professional practice.

During June, we attended the Inter-American Congress on Cardiology, in which several cardiologists representing our Society participated. We also attended the XXIX Dominican Congress on Cardiology and the II Congress on Cardiovascular Surgery 2023, being the only South American country invited.

The Congress of Imaging will soon be held, and it is always welcomed by the medical community, which is interested in the novelties on the diagnosis of cardiovascular diseases.

We continue working on position statements, such as the one on sodium-glucose linked transporter-2 inhibitors (SGLT2i), which was created in conjunction with other societies and is to be published soon.

We continue building projects and firmly believing that Cardiology is an exciting specialty. Although residencies in different public and private institutions are not able to fill the vacancies, we continue betting to enrich this scientific field as much as the evolution of the national management and our everlasting heart impulse allow us to do so.